A block trade is set to sell shares in Nephroplus at an offer price of Rs 705 per share, a 5% discount to Nephrocare Health Services’ closing price of Rs 741.90 on Wednesday. The sale is expected to involve up to a Rs 650-crore stake, with details pointing to participation by promoters and private equity investors.
NDTV reports that Investcorp and Bessemer are among the likely investors that plan to offload their holdings, alongside promoter sellers. The outlets provide the same key deal terms—offer price and the projected value range—while focusing on different combinations of likely selling shareholders. Both reports frame the transaction as a block deal structured around the quoted per-share price, with the total stake size capped at about Rs 650 crore.
While the reporting aligns on pricing and overall value, it varies slightly in emphasis on which parties are expected to sell, reflecting differences in how each outlet lists the anticipated participants rather than changes in the deal mechanics.
